NL-OMON28742尚未招募不适用
The role of tissue factor pathway inhibitor in the development and progression of ischemic cerebral lesions due to cerebral micro-angiopathy
niversity Hospital Maastricht,PO Box 58006202 AZ MaastrichtThe Netherlands0 个研究点目标入组 30 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. First ever lacunar stroke patient (>18 years old)
排除标准
- •1. Use of oral anticoagulants, heparin (derivates) of substances with ulcerogenic action (adrenal gland hormones or anti-rheumatic medication).
研究者
相似试验
已完成
不适用
The role of tissue factor pathway inhibitor in the development and progression of ischemic cerebral lesions due to cerebral micro-angiopathyLacunar stroke. Stroke.1000796310014523NL-OMON31866Academisch Ziekenhuis Maastricht30
已完成
不适用
In Vitro Correction of Thrombin Generation by Concizumab (Anti-TFPI) for Severe Hemophilia PatientsHemophiliaNCT05617209Centre Hospitalier Universitaire de Saint Etienne20
已完成
不适用
TIFACT Study - Tissue Factor Expression by Adipose Tissue in Extremely Obese Subjects.ObesityNCT00379704Assistance Publique - Hôpitaux de Paris85
进行中（未招募）
1 期
Effectiveness of anti TNFalpha agents in Behcet¿s diseaseBEH¿ET¿S DISEASE REFRACTORY TO STANDARD OF CARE THERAPIESMedDRA version: 20.0Level: LLTClassification code 10004215Term: Behcets diseaseSystem Organ Class: 100000004866EUCTR2017-000845-39-ITAZIENDA OSPEDALIERO-UNIVERSITARIA PISANA46
已完成
不适用
Study of TNF-Antagonism in Metabolic SyndromeMetabolic SyndromeNCT00409318Massachusetts General Hospital56